1. CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL‐17 in a STAT3‐dependent manner. Issue 8 (3rd July 2013) Authors: Afzali, Behdad; Mitchell, Peter J.; Edozie, Francis C.; Povoleri, Giovanni A.M.; Dowson, Sophie E.; Demandt, Laura; Walter, Gina; Canavan, James B.; Scotta, Cristiano; Menon, Bina; Chana, Prabhjoat S.; Khamri, Wafa; Kordasti, Shahram Y.; Heck, Susanne; Grimbacher, Bodo; Tree, Timothy; Cope, Andre... Journal: European journal of immunology Issue: Volume 43:Issue 8(2013:Aug.) Page Start: 2043 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Molecular Comparison of Adult and Pediatric Ulcerative Colitis Indicates Broad Similarity of Molecular Pathways in Disease Tissue. Issue 1 (July 2018) Authors: Li, Katherine; Strauss, Richard; Ouahed, Jodie; Chan, Daphne; Telesco, Shannon E.; Shouval, Dror S.; Canavan, James B.; Brodmerkel, Carrie; Snapper, Scott B.; Friedman, Joshua R. Journal: Journal of pediatric gastroenterology and nutrition Issue: Volume 67:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S723 Duration of Response to Ozanimod After Treatment Withdrawal: Results From the Phase 3 True North Study. (October 2022) Authors: Abraham, Bincy; Bressler, Brian; Reinisch, Walter; Jain, Anjali; Memaj, Arteid; Akukwe, Lucy; Liu, W. Jerry; Osterman, Mark; Canavan, James B.; Vermeire, Séverine Other Names: Sands Bruce E. presenter. Journal: American journal of gastroenterology Issue: Volume 117:Number 10(2022)supplement 10S Page Start: e506 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. S731 Ozanimod Is an Effective Oral Treatment for Patients With Ulcerative Colitis Regardless of Baseline Endoscopic Disease Distribution: A Post Hoc Analysis of the Phase 3 True North Study. (October 2022) Authors: Dignass, Axel; Fischer, Monika; Sninsky, Charles; Armuzzi, Alessandro; Wu, Chun; Ahmad, Harris A.; Memaj, Arteid; Harris, Sarah; Canavan, James B.; Schreiber, Stefan Other Names: Afzali Anita presenter. Journal: American journal of gastroenterology Issue: Volume 117:Number 10(2022)supplement 10S Page Start: e513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. S732 Ozanimod Is an Effective Oral Treatment for Patients With Ulcerative Colitis Regardless of Moderate orSevere Endoscopic Disease Activity at Baseline: A Post Hoc Analysis of the Phase 3 True North Study. (October 2022) Authors: Panaccione, Remo; Blumenstein, Irina; Long, Millie; Abraham, Bincy; Jain, Anjali; Memaj, Arteid; Wu, Chun; Hobbs, Vanessa; Harris, Sarah; Canavan, James B.; Peyrin-Biroulet, Laurent Other Names: Wolf Douglas C. presenter. Journal: American journal of gastroenterology Issue: Volume 117:Number 10(2022)supplement 10ES Page Start: e514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. S757 Efficacy and Safety of 2 Years of Continuous Ozanimod Treatment: Interim Analysis of the True North Open-Label Extension Study. (October 2022) Authors: Dulai, Parambir; Dignass, Axel; Savarino, Edoardo; Hudesman, David; Afzali, Anita; Jairath, Vipul; Osterman, Mark; Akukwe, Lucy; Liu, W. Jerry; Memaj, Arteid; Petersen, AnnKatrin; Jain, Anjali; Canavan, James B.; Vermeire, Séverine Other Names: Abreu Maria T. presenter. Journal: American journal of gastroenterology Issue: Volume 117:Number 10(2022)supplement 10S Page Start: e537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. S825 Efficacy of Ozanimod in Vedolizumab-Exposed Patients With Ulcerative Colitis: A Phase 3 True North Post Hoc Analysis. (October 2022) Authors: Jain, Anjali; Ahmad, Harris A.; Osterman, Mark; Memaj, Arteid; Canavan, James B.; Axelrad, Jordan Other Names: Sands Bruce E. presenter. Journal: American journal of gastroenterology Issue: Volume 117:Number 10(2022)supplement 10ES Page Start: e593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗